| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 70801-07-9 | 2-甲基-2-丙烯酸-2-[(1,1-二甲基乙基)氨基]乙酯與2-甲基-2-丙烯酸甲酯、1,2-丙二醇單(2-甲基-2-丙烯酸酯)、 | 2-Propenoic acid, 2-methyl-, 2-[(1,1-dimethylethyl) amino] ethyl ester, polymer with methyl 2-methyl | 無 | (C11H21NO.C10H19NO2.C7H12O3.C5H8O2.C3H4O2)x | 詳情 | 供應商 |
| 802593-28-8 | Acetamide,2-(butylamino)-N-(3,5-dimethyl-4-isoxazolyl)-; Acetamide, 2-(butylamino)-N-(3,5-dimethyl-4-isoxazolyl)- (8CI) |  | C11H19N3O2 | 詳情 | 供應商 | |
| 5588-22-7 | Benzenemethanol,2-chloro-a-[[(1-methylethyl)amino]methyl]-,hydrochloride, hydrate (1:1:1); Benzenemethanol,2-chloro-a-[[(1-methylethyl)amino]methyl]-,hydrochloride, monohydrate (9CI); Benzyl alcohol, o-chloro-a-[(isopropylamino)methyl]-,hydrochloride, monohydrate (8CI); 1-(o-Chlorophenyl)-2-(isopropylamino)ethanolhydrochloride hydrate; 20025; Clorprenaline hydrochloride hydrate; Compound20025; Isoprophenamine hydrochloride hydrate; o-Chloro-a-[(isopropylamino)methyl]benzylalcohol hydrochloride hydrate |  | C11H19Cl2NO2 | 詳情 | 供應商 | |
| 819075-42-8 | Carbamic acid,[(1S)-1-(4-methyl-1H-imidazol-2-yl)ethyl]-, 1,1-dimethylethyl ester (9CI); (S)-[1-(5-methyl-1H-imidazol-2-yl)ethyl]carbamicacid tert-butyl ester |  | C11H19N3O2 | 詳情 | 供應商 | |
| 796845-51-7 | Carbamic acid,N-[2-(1-methyl-1H-pyrazol-5-yl)ethyl]-, 1,1-dimethylethyl ester; Carbamicacid, [2-(1-methyl-1H-pyrazol-5-yl)ethyl]-, 1,1-dimethylethyl ester (9CI); tert-Butyl [2-(1-methyl-1H-pyrazol-5-yl)ethyl]carbamate |  | C11H19N3O2 | 詳情 | 供應商 | |
| 186202-31-3 | Carbamic acid,[2,2,2-trifluoro-1-(3-pyrrolidinyl)ethyl]-, 1,1-dimethylethyl ester (9CI); (2,2,2-Trifluoro-1-pyrrolidin-3-yl-ethyl)-carbamic acid tert-butyl ester |  | C11H19F3N2O2 | 詳情 | 供應商 | |
| 102570-84-3 | Hydrazine,[2-(2,6-dimethoxyphenyl)-1-methylethyl]-, hydrochloride (1:1); Hydrazine,(2,6-dimethoxy-a-methylphenethyl)-,hydrochloride (6CI); Hydrazine, [2-(2,6-dimethoxyphenyl)-1-methylethyl]-,monohydrochloride (9CI) |  | C11H19ClN2O2 | 詳情 | 供應商 | |
| 102570-95-6 | Hydrazinium,1-[(3,4-dimethoxyphenyl)methyl]-1,1-dimethyl-, chloride (1:1); Hydrazinium,1-[(3,4-dimethoxyphenyl)methyl]-1,1-dimethyl-, chloride (9CI) |  | C11H19ClN2O2 | 詳情 | 供應商 | |
| 5543-44-2 | Phosphorodithioic acid,S-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl] O,O-diethyl ester; Methanethiol,[(4,6-dimethyl-2-pyrimidinyl)thio]-, S-ester with O,O-diethylphosphorodithioate |  | C11H19N2O2PS3 | 詳情 | 供應商 | |
| 108993-56-2 | Piperazinium,4-(ethoxycarbonyl)-1-methyl-1-(2-propyn-1-yl)-, bromide (1:1); 4-Carboxy-1-methyl-1-(2-propynyl)piperaziniumbromide, ethyl ester (6CI) |  | C11H19BrN2O2 | 詳情 | 供應商 | |
| 152645-67-5 | Sylverin (reduced)(9CI); L-Proline,L-seryl-L-isoleucyl-L-lysyl-L-a-glutamyl-L-lysyl-L-isoleucyl-L-cysteinyl-L-lysyl-L-isoleucyl-L-isoleucyl-L-a-glutamyl-L-alanyl-L-lysyl-L-isoleucylglycyl-L-lysyl-L-lysyl-L-prolyl-L-prolyl-L-phenylalanyl-L-cysteinyl- |  | C114H196N28O28S2 | 詳情 | 供應商 | |
| 857530-80-4 | 1H-Pyrazole,3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-; (3,5-Dimethyl-1H-pyrazol-4-yl)boronicacid pinacol ester; 3,5-Dimethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole |  | C11H19BN2O2 | 詳情 | 供應商 | |
| 110358-89-9 | 2-Furancarboxamide,N-[2-(diethylamino)ethyl]-, hydrochloride (1:1); 2-Furamide,N-(2-diethylaminoethyl)-, hydrochloride (6CI) |  | C11H19ClN2O2 | 詳情 | 供應商 | |
| 56605-19-7 | 2,4-Imidazolidinedione,3-[2-[bis(2-chloroethyl)amino]ethyl]-5,5-dimethyl-; NSC 172113 |  | C11H19Cl2N3O2 | 詳情 | 供應商 | |
| 847818-70-6 | 1-Ethyl-1H- |  | C11H19BN2O2 | 詳情 | 供應商 | |
| 32908-73-9 | MAST CELL DEGRANULATING PEPTIDE | MAST CELL DEGRANULATING PEPTIDE; isulfide); mastcelldegranulatingpeptide(honeybee); mastcelldegranulatingpeptide(honeybeereduced)cyclic(3-15),(5-19)-bis(d; H-ILE-LYS-+CYS-ASN-++CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-+CYS-ARG-LYS- ILE-++CYS-GLY-LYS-ASN-NH2; H-ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2; H-ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2 (RANDOM CYCLIZATION); IKCNCKRHVIKPHICRKICGKN-NH2; ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2 |  | C110H192N40O24S4 | 詳情 | 供應商 |
| 675112-67-1 | N-T-BOC-4,4-DIFLUOROCYCLOHEXYLAMINE |  | C11H19F2NO2 | 詳情 | 供應商 | |
| 886766-28-5 | tert-Butyl-4,7-diazaspiro[2.5] |  | C11H19N2O2- | 詳情 | 供應商 | |
| 86408-36-8 | POLYMYXIN B NONAPEPTIDE HYDROCHLORIDE; POLYMYXIN B NONAPEPTIDE HYDROCHLORIDE; polymyxinbnonapeptide; N2-(L-Thr-L-A2bu-)Cyclo(L-A2bu*-L-A2bu-D-Phe-L-Leu-L-A2bu-L-A2bu-L-Thr-); N2-(L-Thr-L-A2bu-)Cyclo(L-A2bu*-L-A2bu-D-Phe-L-Leu-L-A2bu-L-A2bu-Thr-); Nα-(L-Thr-L-A2bu-)Cyclo(L-A2bu*-L-A2bu-D-Phe-L-Leu-L-A2bu-L-A2bu-L-Thr-); PMBN; sPMBN |  | C111H194N32O26 | 詳情 | 供應商 | |
| 83856-13-7 | ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE- CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2(DISULFIDE BRIDGE CYS3-CYS15, CYS5-CYS19); ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE- CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2(DISULFIDE BRIDGE CYS3-CYS15, CYS5-CYS19); ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2: IKCNCKRHVIKPHICRKICGKN-NH2 DISULFIDE BRIDGES CYS3-CYS15, CYS5-CYS19 | MAST CELL DEGRANULATING PEPTIDE; MAST CELL DEGRANULATING PEPTIDE; MAST CELL DEGRANULATING PEPTIDE (APIS MELLIFERA); MAST CELL DEGRANULATING (MCD) PEPTIDE; MCD; MCD PEPTIDE; MCD PEPTIDE (APIS MELLIFERA); H-ILE-LYS-+CYS-ASN-++CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-+CYS-ARG-LYS- ILE-++CYS-GLY-LYS-ASN-NH2; H-ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2 | 無 | C110H192N40O24S4 | 詳情 | 供應商 |